Industry Specific Training Courses

If you can't find what you want, Ask Us.

Refine Your Results

reset

Filter by Category

Location

Dates

FEATURED VENDORS

Showing 1-20 of 1518 results Sort by:

Courses

  • 1 Request Info

    Identity Issues in Banking - 2 CPEs

    Do you really understand the list of Federal regulations concerning identity issues? This webinar training helps attendees to understand the problems with 26 Red flags released by federal regulators in regards to identity fraud. The instructor will discuss how to create and implement the fraud control program and identity solutions to combat ID theft and reduce future losses. What is going on with regard to customer ID and the Equifax data breach? We now know this breach was must like a Chinese Army operation. Banks have been increasingly dependent on Credit Agencies' data to support their customer identity needs. After the data breach at Experian, fraudsters buying data on the Dark Web have access to the same credit report data that the bank does. Banks need to do some basic rethinking about customer and potential customer identity issues, and they need to do that quickly. This is going to require creative thinking, as there is no "solution" in a box on the shelf.
  • 2 Request Info

    Red Flags and High-Risk AML Transactions - 2 CPEs

    Anti-money laundering (AML) policies and procedures are a hot topic! Is your bank feeling pain from this intensifying regulatory requirement for the financial institution? Properly managing high-risk transactions is a basic requirement in the banking industry. This event is focused on helping the bank to avoid reporting failures which can lead to sanctions. This event covers both the identification and the management aspects of high-risk transactions within the financial institution. Much of the session we will discuss actual money laundering strategies and techniques. And for each, what are the Red Flags such activities should raise? Missing "Red Flags" indicating money laundering can take place at your bank. The failure to file a SARs has potential regulatory ramifications. This event looks at money laundering detection from a very different point of view. Most bankers will go their entire careers without uncovering a case of money laundering.
  • 3 Request Info

    FinCEN's CDD Rule - 2 CPEs

    Learn about the FinCIN CDD requirements and how to be fully compliant. These FinCIN requirements are extensive and involve research into entities few banks previously documented well within their client base. The U.S. Department of the Treasury's Financial Crimes Enforcement Network ("FinCEN") issued a final rule requiring the minimum standards for anti-money laundering programs for certain institutions lacking a Federal functional regulator. It is focused beyond the initial customer acceptance step, requiring updating and ongoing monitoring against baseline "normal" activity for the customer type. Until CDD became a requirement not many banks already complied with these requirements. Full compliance implementation is required on accounts opened on or after May 11, 2018.
  • 4 Request Info

    Employee Fraud at Banks - 2 CPEs

    Which industry has the most reported occupational fraud schemes? Banking!!! Banking organizations are increasingly threatened by employee fraud. In fact, employee fraud represents the majority of all fraud threats to a banking organization. Embezzlement, kickbacks, check fraud, financial statement fraud and vendor billing schemes are just a few of the countless economic crimes committed by employees and outsiders. And with the march of technology, new computer and Internet-driven schemes are being deployed by dishonest insiders all the time. This webinar will provide attendees with a strong foundation of practical knowledge about how common frauds are committed, how to detect the red flags of these crimes and how to eliminate control deficiencies that provide opportunities for dishonest employees.
  • 5 Request Info

    Banking Compliance Failures - 2 CPEs

    The level of fines levied against banks resulting from failure to comply with various regulations has soared, reaching into the billions of dollars in individual instances. Every bank organization is responsible for compliance with a wide variety of regulations. Compliance failures are risks to both the bank's reputation and its stockholders. There is an increasing discussion that, rather than punish stockholders, individual officers should be personally held accountable for their decisions in causing failures to act in compliance. Already the Sarbanes-Oxley law specifically requires that companies, including banks, have accurate financial reports as well as sound controls which are required to assure the material accuracy of those reports. CEOs and CFOs have to personally sign statements to that effect and can be charged personally under some circumstances.
  • 6 Request Info

    Banking Best Practices to Prevent Fraud - 2 CPEs

    This event takes a hard look at preventing fraud in the retail banking organization. It gives you an execelant overview of a bank organization's best practices to prevent fraud. Attend to improve the anti-fraud efforts at your institution. Fraud is of more concern to banking leaders today than ever before. These concerns are driven by national media coverage, social media reports, actual dollar losses, the attack on trust (which is key to customer relationships), costs to allay customer concerns, changing regulatory environment, and changes in how fraud efforts are being organized. Fraud is no longer just a "cottage industry", it is moving to an industrial model where specialists steal data and sell it to others who organize high-volume attacks by multiple perpetrators. Banks cannot combat the "Fraud Industry" with yesterday's methods.
  • 7 Request Info

    AML/BSA Basics and Compliance - 2 CPEs

    Money laundering continues to be a national concern. High levels of drug-related activity and violence have drawn additional attention. Terrorist activities need to be considered as well. Perpetrators have adapted to a banks' efforts so that banks cannot combat the money laundering with yesterday's methods. Software is widely installed to identify specific patterns and "unusual" transactions. But the fraudsters know this and are constantly striving to create new patterns where their transactions are designed not to be flagged. Like in a game of chess, the advantage goes to the side that thinks the most moves ahead. FinCEN has issued substantial new AML requirements focused on a major expansion of Know Your Customer into what is now Customer Due Diligence, CDD. The requirements go far beyond the basic knowledge of the Customer Legal Entity to the Beneficial Owner of that entity and its Controlling Persons. The requirements force the bank to focus beyond initial acceptance.
  • 8 Request Info

    6-Hour Virtual Seminar - Batch Record Review and Product Release

    Most Regulatory Agencies require firms to have written procedures in place to document production and process controls, better known as batch records. Additionally, there must be written procedures for a batch record review process that demonstrate compliance. A strong batch record review system is essential in order to properly document all critical processing parameters that go along with the production and manufacture of pharmaceuticals, biologics, medical devices, etc. This webinar will analyze each of these necessary elements of the batch record review process.
  • 9 Request Info

    6-Hour Virtual Seminar on EU Regulatory Affairs strategy during development of medicinal products

    The main document from a regulatory perspective in the development of a medicinal product is the regulatory plan. In this Seminar it is explained how to write the regulatory plan, and which aspects to consider. The regulatory plan describes the regulatory strategy, as well as pricing and reimbursement issues in your development. Orphan Medicinal Products will be discussed, and the advantages of having a status as an orphan medicinal product will be explained. Incentives for the development of orphan medicinal products have been available in the United States of America since 1983 and in Japan since 1993, and also the EU offers a range of incentives to encourage the development of these medicines.
  • 10 Request Info

    6-Hour Virtual Seminar on Biostatistics for the Non-Statistician

    Statistics is a useful decision making tool in the clinical research arena. When working in a field where a p-value can determine the next steps on development of a drug or procedure, it is imperative that decision makers understand the theory and application of statistics. Why you should attend Many statistical softwares are now available to professionals. However, these softwares were developed for statisticians and can often be daunting to non-statisticians. How do you know if you are pressing the right key, let alone performing the best test?
  • 11 Request Info

    6-Hour Virtual Seminar on EU Regulatory Affairs strategy during development of medicinal products

    Overview The main document from a regulatory perspective in the development of a medicinal product is the regulatory plan. In this Seminar it is explained how to write the regulatory plan, and which aspects to consider. The regulatory plan describes the regulatory strategy, as well as pricing and reimbursement issues in your development. Orphan Medicinal Products will be discussed, and the advantages of having a status as an orphan medicinal product will be explained. Incentives for the development of orphan medicinal products have been available in the United States of America since 1983 and in Japan since 1993, and also the EU offers a range of incentives to encourage the development of these medicines.
  • 12 Request Info

    6-Hour Virtual Seminar on Biostatistics for the Non-Statistician

    Overview Statistics is a useful decision making tool in the clinical research arena. When working in a field where a p-value can determine the next steps on development of a drug or procedure, it is imperative that decision makers understand the theory and application of statistics. Why you should attend Many statistical softwares are now available to professionals. However, these softwares were developed for statisticians and can often be daunting to non-statisticians. How do you know if you are pressing the right key, let alone performing the best test?
  • 13 Request Info

    6-Hour Virtual Seminar - Medical Claims Boot Camp - Cracking the Code

    Overview This course covers the fundamentals of medical billing, coding, and reimbursement by explaining how all of these components work together. Emphasis will be placed on the practical application of the latest industry knowledge and standards, with the goal of helping those who work with medical claims and claims data stay ahead of the game. Participants will learn about the following: The claim flow process from registration through adjudication and payment How physicians and hospitals set and manage charges Critical data elements on the two major claim forms and what they mean How and why the major coding systems are utilized How various reimbursement methods are used by payors
  • 14 Request Info

    How Blockchain Will Become the Basis for An Integrated Food Safety System (IFFS)

    Overview: If you have been wondering what all this jazz about Blockchain is or how it might impact your position in the food supply chain, you need to take and hour to learn what's going on. In this webinar, blockchain will be simply described and the likely food safety and quality inputs to this invoicing system are likely to determine your company's financial future. As the large tier 1 companies like Walmart (and Kroger, Unilever, Nestle, Dole, and many others) adopt blockchain, the likelihood that all food supply chain players are destined to be forced into participation is very high.
  • 15 Request Info

    Pharmaceutical Compressed Air - Quality GMP Standards and Requirements

    Overview: Compressed air for pharmaceutical use is considered a critical utility as many of its applications involve direct contact with the pharmaceutical product. The design, construction and monitoring of a compressed air system is essential for maintaining a quality system without contamination of the product. Proper testing of compressed air quality according to international standards is important for both validation and ongoing monitoring of the system.
  • 16 Request Info

    Mobile Apps as Medial Devices

    Overview: Some of these new mobile apps / software functions are specifically targeted to assisting individuals in their own health and wellness management. Others are targeted to health care providers as tools to improve and facilitate the delivery of patient care. These software devices include products that feature one or more software components, parts, or accessories, as well as devices that are composed solely of software.
  • 17 Request Info

    6-Hour Virtual Seminar on Batch Record Review and Product Release

    Most Regulatory Agencies require firms to have written procedures in place to document production and process controls, better known as batch records. Additionally, there must be written procedures for a batch record review process that demonstrate compliance. A strong batch record review system is essential in order to properly document all critical processing parameters that go along with the production and manufacture of pharmaceuticals, biologics, medical devices, etc. This webinar will analyze each of these necessary elements of the batch record review process.
  • 18 Request Info

    4-Hour Virtual Seminar on Good Laboratory Practices (GLPs)

    The objective of this webinar is to compare and contrast between Good Laboratory Practices and Good Manufacturing practices Why you should attend Good Laboratory Practices (GLPs), 21 CFR part 58 are not set of guidelines but they are regulations for conducting nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for products such as food and color additives, human and animal drugs, medical devices for human use, biological products and electronic products that are regulated by the FDA.
  • 19 Request Info

    6-Hour Virtual Seminar on FDA Trends for Computer System Validation (CSV)

    Upon completion of this session, attendees will have an understanding of FDA compliance and enforcement as it relates to computer system validation. They will understand how to develop the most robust computer system validation compliance program, focusing on the critical areas of interest to FDA. The attendees will have a good grasp of how to identify potential weaknesses and findings, as well as how to make recommendations for addressing and remediating them through risk mitigation.
  • 20 Request Info

    6-Hour Virtual Seminar on Statistical Process Control & Process Capability

    Statistical Process Control charts have been called the Voice of the Process. Progressive manufacturers utilize control charts to "listen" to their processes so that potentially harmful changes will be quickly detected and rectified. However, not all SPC programs deliver to their highest capability as there are many elements to get right to achieve maximum utility. Highly effective SPC programs combine technical competencies, such as using an appropriate chart and sample size for the application, with effective management techniques such as enabling operator buy-in and involvement. This webinar provides a comprehensive introduction to SPC methods and tools to help you deploy an effective SPC program.